Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Net Cash Flow (2020 - 2025)

Vivos Therapeutics has reported Net Cash Flow over the past 6 years, most recently at -$1.0 million for Q4 2025.

  • Quarterly Net Cash Flow fell 9072.73% to -$1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$15.7 million through Dec 2025, down 440.52% year-over-year, with the annual reading at -$4.2 million for FY2025, 191.82% down from the prior year.
  • Net Cash Flow was -$1.0 million for Q4 2025 at Vivos Therapeutics, up from -$1.4 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $20.2 million in Q2 2021 and troughed at -$9.4 million in Q2 2025.
  • The 5-year median for Net Cash Flow is -$3.0 million (2023), against an average of -$1.4 million.
  • Year-over-year, Net Cash Flow soared 6475.83% in 2021 and then tumbled 9072.73% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$4.5 million in 2021, then increased by 28.95% to -$3.2 million in 2022, then soared by 121.97% to $703000.0 in 2023, then tumbled by 101.56% to -$11000.0 in 2024, then tumbled by 9072.73% to -$1.0 million in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Net Cash Flow are -$1.0 million (Q4 2025), -$1.4 million (Q3 2025), and -$9.4 million (Q2 2025).